TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
SEPN

Septerna, Inc.

Healthcare · Biotechnology · —

38.10$ -0.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow SEPN
Line item 2022 2023 2024 2025
– – – –
– +47.0% +65.2% +14.5%
– +6.6% +94.6% +168.9%
– -47.0% -73.2% +65,535.9%
– +123.3% -26.9% -75.4%
– – -826.0% +42.8%
– – +0.0% +0.0%
– +148.0% +407.0% -99.6%
– +961.0% +158.5% -178.5%
– – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?